Dr. Strosberg on FDA Approval of Lutathera for GEP-NETs

Video

In Partnership With:

Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the FDA approval of Lutathera (177Lutetium DOTA-octreotate) as a treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the FDA approval of Lutathera (177Lutetium DOTA-octreotate) as a treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Related Videos
Rohan Garje, MD, chief, Genitourinary Medical Oncology, Baptist Health Miami Cancer Institute
Changchun Deng, MD, PhD, associate professor, hematology/oncology, University Hospitals Seidman Cancer Center; member, Immune Oncology Program, Case Comprehensive Cancer Center
Jaime R. Merchán, MD
Erin Frances Cobain, MD
Mark D. Tyson, II, MD, MPH
Michael Iglesia, MD, PhD
Sundar Jagannath, MBBS
Jonathan E. Rosenberg, MD
Núria Agustí Garcia, MD
Erin Frances Cobain, MD
Related Content
Rami Komrokji, MD, vice chair, the Malignant Hematology Department, head, the Leukemia and Myelodysplastic Syndromes Section, Moffitt Cancer Center

NCCN Lists Ropeginterferon Alfa-2B As Preferred First-Line Cytoreductive Therapy for Polycythemia Vera

February 28th 2024
Article
Andrew Kuykendall, MD

FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

October 16th 2023
Podcast
Jobelle Baldonado, MD, of Moffitt Cancer Center

Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer

February 19th 2024
Article
Nikhil I. Khushalani, MD; Martin F. Dietrich, MD, PhD; Jason J. Luke, MD, FACP; Vishal A. Patel, MD, FAAD, FACMS

CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice

March 6th 2023
Podcast
State of the Science Summit - Lung Cancer: Chaired by Jobelle Baldonado, MD, and Jhanelle Gray, MD

State of the Science Summit - Lung Cancer: Chaired by Jobelle Baldonado, MD, and Jhanelle Gray, MD

February 1st 2024
Article
Andrew Kuykendall, MD

Regulatory Decisions and Research Boost Management Strategies for Hematologic Malignancies

November 15th 2023
Article